Proposed Substances To Be Evaluated for Set 30 Toxicological Profiles, 15110-15111 [2016-06277]

Download as PDF 15110 Federal Register / Vol. 81, No. 54 / Monday, March 21, 2016 / Notices 3,000 finance companies has been drawn for the FR 3033s. The survey will be sent on March 21, 2016, and will collect detailed information, as of December 31, 2015, from both assets and liability sides of the respondents’ balance sheets, along with income and expenses, the number of accounts and offices, and the small-business credit they extend, if any. The data collected from this voluntary survey will be used for two purposes: to benchmark the consumer and business finance series collected on the monthly Domestic Finance Company Report of Consolidated Assets and Liabilities (FR 2248; OMB No. 7100–0005) and to increase the Board’s understanding of an important part of the financial system. Current Actions: On January 12, 2016, the Federal Reserve published a notice in the Federal Register (81 FR 1421) requesting public comment for 60 days on the proposal to extend the FR 3033s for three years and to revise the survey by adding a section to solicit information from the finance companies on income and expenses, number of accounts and offices, and small business credit they extend. The comment period for the notice expired on March 14, 2016. The Federal Reserve did not receive any comments, and the information collection will be revised as proposed. must be received not later than April 5, 2016. A. Federal Reserve Bank of Kansas City (Dennis Denney, Assistant Vice President) 1 Memorial Drive, Kansas City, Missouri 64198–0001: 1. Jerry G. Scott, as trustee of the Jerry G. Scott Trust, both of Seminole, Oklahoma, and individually as a voting representative, John Barry Barringer, Ardmore, Oklahoma; Lisa B. Boggs, Sulphur, Oklahoma; Hugh B. Warren, Jr., and Allene L. Warren, both of Ada, Oklahoma, as members, of the Vision Bancshares, Inc. Shareholders’ Agreement, Seminole, Oklahoma; to retain voting shares of Vision Bancshares, Inc., and thereby indirectly retain voting shares of Vision Bank, N.A., both in Ada, Oklahoma. 2. Twila V. Gregg, and Richard A. Gregg, both of Lee’s Summit, Missouri; to acquire voting shares of Urich Bancorp, Inc., and thereby indirectly acquire voting shares of America’s Community Bank, both in Blue Springs, Missouri. Board of Governors of the Federal Reserve System, March 16, 2016. Michael J. Lewandowski, Associate Secretary of the Board. [FR Doc. 2016–06256 Filed 3–18–16; 8:45 am] at the Reserve Bank indicated or the offices of the Board of Governors not later than April 5, 2016. A. Federal Reserve Bank of Minneapolis (Jacquelyn K. Brunmeier, Assistant Vice President) 90 Hennepin Avenue, Minneapolis, Minnesota 55480–0291: 1. Park Financial Group, Inc., Minneapolis, Minnesota; to engage de novo in extending credit and servicing loans, pursuant to section 225.28(b)(1). B. Federal Reserve Bank of Kansas City (Dennis Denney, Assistant Vice President) 1 Memorial Drive, Kansas City, Missouri 64198–0001: 1. Washington 1st Banco, Inc., Washington, Kansas; to continue to engage de novo in extending credit and servicing loans, pursuant to section 225.28(b)(1). Board of Governors of the Federal Reserve System, March 16, 2016. Michael J. Lewandowski, Associate Secretary of the Board. [FR Doc. 2016–06255 Filed 3–18–16; 8:45 am] BILLING CODE 6210–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 6210–01–P Agency for Toxic Substances and Disease Registry FEDERAL RESERVE SYSTEM [Docket No. ATSDR–2016–0004] Board of Governors of the Federal Reserve System, March 16, 2016. Robert deV. Frierson, Secretary of the Board. Notice of Proposals To Engage in or To Acquire Companies Engaged in Permissible Nonbanking Activities Proposed Substances To Be Evaluated for Set 30 Toxicological Profiles [FR Doc. 2016–06278 Filed 3–18–16; 8:45 am] The companies listed in this notice have given notice under section 4 of the Bank Holding Company Act (12 U.S.C. 1843) (BHC Act) and Regulation Y, (12 CFR part 225) to engage de novo, or to acquire or control voting securities or assets of a company, including the companies listed below, that engages either directly or through a subsidiary or other company, in a nonbanking activity that is listed in § 225.28 of Regulation Y (12 CFR 225.28) or that the Board has determined by Order to be closely related to banking and permissible for bank holding companies. Unless otherwise noted, these activities will be conducted throughout the United States. Each notice is available for inspection at the Federal Reserve Bank indicated. The notice also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the question whether the proposal complies with the standards of section 4 of the BHC Act. Unless otherwise noted, comments regarding the notices must be received BILLING CODE 6210–01–P FEDERAL RESERVE SYSTEM mstockstill on DSK4VPTVN1PROD with NOTICES Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire shares of a bank or bank holding company. The factors that are considered in acting on the notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)). The notices are available for immediate inspection at the Federal Reserve Bank indicated. The notices also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board of Governors. Comments VerDate Sep<11>2014 17:46 Mar 18, 2016 Jkt 238001 PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 Agency for Toxic Substances and Disease Registry (ATSDR), Department of Health and Human Services (HHS). ACTION: Request for comments on the proposed substances to be evaluated for Set 30 toxicological profiles. AGENCY: ATSDR is initiating the development of its 30th set of toxicological profiles (CERCLA Set 30). This notice announces the list of proposed substances that will be evaluated for CERCLA Set 30 toxicological profile development. ATSDR’s Division of Toxicology and Human Health Sciences is soliciting public nominations from the list of proposed substances to be evaluated for toxicological profile development. ATSDR also will consider the nomination of any additional, nonCERCLA substances that may have public health implications, on the basis of ATSDR’s authority to prepare toxicological profiles for substances not found at sites on the National Priorities List. The agency will do so in order to ‘‘. . . establish and maintain inventory SUMMARY: E:\FR\FM\21MRN1.SGM 21MRN1 Federal Register / Vol. 81, No. 54 / Monday, March 21, 2016 / Notices of literature, research, and studies on the health effects of toxic substances’’ under CERCLA Section 104(i)(1)(B), to respond to requests for consultation under section 104(i)(4), and to support the site-specific response actions conducted by ATSDR, as otherwise necessary. Nominations from the Substance Priority List and/or additional substances must be submitted within 30 days of the publication of this notice. DATES: You may submit nominations, identified by Docket No. ATSDR–2016–0004, by any of the following methods: *Internet: Access the Federal eRulemaking portal at https:// www.regulations.gov. Follow the instructions for submitting comments. *Mail: Division of Toxicology and Human Health Sciences, 1600 Clifton Rd. NE., MS F–57, Atlanta, GA 30333 Instructions: All submissions must include the agency name and docket number for this notice. All relevant comments will be posted without change. This means that no confidential business information or other confidential information should be submitted in response to this notice. Refer to the section Submission of Nominations (below) for the specific information required. ADDRESSES: For further information, please contact Commander Jessilynn B. Taylor, Division of Toxicology and Human Health Sciences, 1600 Clifton Rd. NE., MS F–57, Atlanta, GA 30333, Email: jxt1@cdc.gov; phone: 770.488.3313. FOR FURTHER INFORMATION CONTACT: The Superfund Amendments and Reauthorization Act of 1986 (SARA) [42 U.S.C. 9601 et seq.] amended the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA or Superfund) [42 U.S.C. 9601 et seq.] by establishing certain requirements for ATSDR and the U.S. Environmental Protection Agency (EPA) with regard to hazardous substances most commonly found at facilities on the CERCLA National Priorities List (NPL). Among these statutory requirements is a mandate for the Administrator of ATSDR to prepare toxicological profiles for each substance included on the Priority List of Hazardous Substances. This list identifies 275 hazardous substances that ATSDR and EPA have determined pose the most significant current potential threat to human health. mstockstill on DSK4VPTVN1PROD with NOTICES SUPPLEMENTARY INFORMATION: VerDate Sep<11>2014 17:46 Mar 18, 2016 Jkt 238001 15111 Substances To Be Evaluated for Set 30 Toxicological Profiles DEPARTMENT OF HEALTH AND HUMAN SERVICES Each year, ATSDR develops a list of substances to be considered for toxicological profile development. The Set 30 nomination process includes consideration of all substances on ATSDR’s Priority List of Hazardous Substances, also known as the Substance Priority List (SPL), as well as other substances nominated by the public. The 275 substances on the SPL, as well as other substances nominated by the public, will be considered for Set 30 Toxicological Profile development. This list may be found at the following Web site: www.atsdr.cdc.gov/SPL. Submission of Nominations for the Evaluation of Set 30 Proposed Substances: Today’s notice invites voluntary public nominations for substances included on the SPL and for substances not listed on the SPL. All nominations should include the full name of the nominator, affiliation, and email address. When nominating a nonSPL substance, please include the rationale for the nomination. Please note that email addresses will not be posted on regulations.gov. ATSDR will evaluate all data and information associated with nominated substances and will determine the final list of substances to be chosen for toxicological profile development. Substances will be chosen according to ATSDR’s specific guidelines for selection. These guidelines can be found in the Selection Criteria announced in the Federal Register on May 7, 1993 (58FR27286–27287). A hard copy of the Selection Criteria is available upon request or may be accessed at: https:// www.atsdr.cdc.gov/toxprofiles/ guidance/criteria_for_selecting_tp_ support.pdf. Please ensure that your comments are submitted within the specified nomination period. Nominations received after the closing date will be marked as late and may be considered only if time and resources permit. Centers for Disease Control and Prevention Dated: March 15, 2016. Pamela Protzel Berman, Acting Associate Director, Office of Policy, Planning and Evaluation, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry. [FR Doc. 2016–06277 Filed 3–18–16; 8:45 am] BILLING CODE 4163–70–P PO 00000 [60Day–16–16TZ; Docket No. CDC–2016– 0028] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: The Centers for Disease Control and Prevention (CDC), as part of its continuing efforts to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project entitled ‘‘Formative Research to Develop HIV Social Marketing Campaigns for Healthcare Providers.’’ CDC seeks a three-year approval to collect data from health care providers in order to develop timely, relevant, clear, and engaging materials that will support patient-provider communications related to HIV prevention. DATES: Written comments must be received on or before May 20, 2016. ADDRESSES: You may submit comments, identified by Docket No. CDC–2016– 0028 by any of the following methods: • Federal eRulemaking Portal: Regulation.gov. Follow the instructions for submitting comments. • Mail: Leroy A. Richardson, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS– D74, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. All relevant comments received will be posted without change to Regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to Regulations.gov. SUMMARY: Please note: All public comment should be submitted through the Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the address listed above. To request more information on the proposed project or to obtain a copy of FOR FURTHER INFORMATION CONTACT: Frm 00078 Fmt 4703 Sfmt 4703 E:\FR\FM\21MRN1.SGM 21MRN1

Agencies

[Federal Register Volume 81, Number 54 (Monday, March 21, 2016)]
[Notices]
[Pages 15110-15111]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-06277]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Toxic Substances and Disease Registry

[Docket No. ATSDR-2016-0004]


Proposed Substances To Be Evaluated for Set 30 Toxicological 
Profiles

AGENCY: Agency for Toxic Substances and Disease Registry (ATSDR), 
Department of Health and Human Services (HHS).

ACTION: Request for comments on the proposed substances to be evaluated 
for Set 30 toxicological profiles.

-----------------------------------------------------------------------

SUMMARY: ATSDR is initiating the development of its 30th set of 
toxicological profiles (CERCLA Set 30). This notice announces the list 
of proposed substances that will be evaluated for CERCLA Set 30 
toxicological profile development. ATSDR's Division of Toxicology and 
Human Health Sciences is soliciting public nominations from the list of 
proposed substances to be evaluated for toxicological profile 
development. ATSDR also will consider the nomination of any additional, 
non-CERCLA substances that may have public health implications, on the 
basis of ATSDR's authority to prepare toxicological profiles for 
substances not found at sites on the National Priorities List. The 
agency will do so in order to ``. . . establish and maintain inventory

[[Page 15111]]

of literature, research, and studies on the health effects of toxic 
substances'' under CERCLA Section 104(i)(1)(B), to respond to requests 
for consultation under section 104(i)(4), and to support the site-
specific response actions conducted by ATSDR, as otherwise necessary.

DATES: Nominations from the Substance Priority List and/or additional 
substances must be submitted within 30 days of the publication of this 
notice.

ADDRESSES: You may submit nominations, identified by Docket No. ATSDR-
2016-0004, by any of the following methods:
    *Internet: Access the Federal eRulemaking portal at https://www.regulations.gov. Follow the instructions for submitting comments.
    *Mail: Division of Toxicology and Human Health Sciences, 1600 
Clifton Rd. NE., MS F-57, Atlanta, GA 30333
    Instructions: All submissions must include the agency name and 
docket number for this notice. All relevant comments will be posted 
without change. This means that no confidential business information or 
other confidential information should be submitted in response to this 
notice. Refer to the section Submission of Nominations (below) for the 
specific information required.

FOR FURTHER INFORMATION CONTACT: For further information, please 
contact Commander Jessilynn B. Taylor, Division of Toxicology and Human 
Health Sciences, 1600 Clifton Rd. NE., MS F-57, Atlanta, GA 30333, 
Email: jxt1@cdc.gov; phone: 770.488.3313.

SUPPLEMENTARY INFORMATION: The Superfund Amendments and Reauthorization 
Act of 1986 (SARA) [42 U.S.C. 9601 et seq.] amended the Comprehensive 
Environmental Response, Compensation, and Liability Act of 1980 (CERCLA 
or Superfund) [42 U.S.C. 9601 et seq.] by establishing certain 
requirements for ATSDR and the U.S. Environmental Protection Agency 
(EPA) with regard to hazardous substances most commonly found at 
facilities on the CERCLA National Priorities List (NPL). Among these 
statutory requirements is a mandate for the Administrator of ATSDR to 
prepare toxicological profiles for each substance included on the 
Priority List of Hazardous Substances. This list identifies 275 
hazardous substances that ATSDR and EPA have determined pose the most 
significant current potential threat to human health.

Substances To Be Evaluated for Set 30 Toxicological Profiles

    Each year, ATSDR develops a list of substances to be considered for 
toxicological profile development. The Set 30 nomination process 
includes consideration of all substances on ATSDR's Priority List of 
Hazardous Substances, also known as the Substance Priority List (SPL), 
as well as other substances nominated by the public. The 275 substances 
on the SPL, as well as other substances nominated by the public, will 
be considered for Set 30 Toxicological Profile development. This list 
may be found at the following Web site: www.atsdr.cdc.gov/SPL.
    Submission of Nominations for the Evaluation of Set 30 Proposed 
Substances: Today's notice invites voluntary public nominations for 
substances included on the SPL and for substances not listed on the 
SPL. All nominations should include the full name of the nominator, 
affiliation, and email address. When nominating a non-SPL substance, 
please include the rationale for the nomination. Please note that email 
addresses will not be posted on regulations.gov.
    ATSDR will evaluate all data and information associated with 
nominated substances and will determine the final list of substances to 
be chosen for toxicological profile development. Substances will be 
chosen according to ATSDR's specific guidelines for selection. These 
guidelines can be found in the Selection Criteria announced in the 
Federal Register on May 7, 1993 (58FR27286-27287). A hard copy of the 
Selection Criteria is available upon request or may be accessed at: 
https://www.atsdr.cdc.gov/toxprofiles/guidance/criteria_for_selecting_tp_support.pdf.
    Please ensure that your comments are submitted within the specified 
nomination period. Nominations received after the closing date will be 
marked as late and may be considered only if time and resources permit.

    Dated: March 15, 2016.
Pamela Protzel Berman,
Acting Associate Director, Office of Policy, Planning and Evaluation, 
National Center for Environmental Health/Agency for Toxic Substances 
and Disease Registry.
[FR Doc. 2016-06277 Filed 3-18-16; 8:45 am]
BILLING CODE 4163-70-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.